519 related articles for article (PubMed ID: 15291015)
1. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Mummaneni PV; Pan J; Haid RW; Rodts GE
J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
[TBL] [Abstract][Full Text] [Related]
2. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
4. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
[TBL] [Abstract][Full Text] [Related]
5. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Burkus JK
J Neurosurg Spine; 2004 Oct; 1(3):254-60. PubMed ID: 15478362
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
8. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
Burkus JK; Gornet MF; Schuler TC; Kleeman TJ; Zdeblick TA
J Bone Joint Surg Am; 2009 May; 91(5):1181-9. PubMed ID: 19411467
[TBL] [Abstract][Full Text] [Related]
9. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
[TBL] [Abstract][Full Text] [Related]
10. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2.
Burkus JK; Dorchak JD; Sanders DL
Spine (Phila Pa 1976); 2003 Feb; 28(4):372-7. PubMed ID: 12590213
[TBL] [Abstract][Full Text] [Related]
11. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
12. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
13. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiographic outcomes using local bone shavings as autograft in minimally invasive transforaminal lumbar interbody fusion.
Kasliwal MK; Deutsch H
World Neurosurg; 2012 Jul; 78(1-2):185-90. PubMed ID: 22120378
[TBL] [Abstract][Full Text] [Related]
15. Comparison of polyetheretherketone cages with femoral cortical bone allograft as a single-piece interbody spacer in transforaminal lumbar interbody fusion.
Cutler AR; Siddiqui S; Mohan AL; Hillard VH; Cerabona F; Das K
J Neurosurg Spine; 2006 Dec; 5(6):534-9. PubMed ID: 17176018
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
[TBL] [Abstract][Full Text] [Related]
17. Twelve-month results of a multicenter, blinded, pilot study of a novel peptide (B2A) in promoting lumbar spine fusion.
Sardar Z; Alexander D; Oxner W; du Plessis S; Yee A; Wai EK; Anderson DG; Jarzem P
J Neurosurg Spine; 2015 Apr; 22(4):358-66. PubMed ID: 25615629
[TBL] [Abstract][Full Text] [Related]
18. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases.
Balseiro S; Nottmeier EW
Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766
[TBL] [Abstract][Full Text] [Related]
19. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Boden SD; Kang J; Sandhu H; Heller JG
Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
